Research / IR / Fundamental state Inspectable configuration
State dimensions Filing 0001140361-20-004146 General Corporate
Debt relative to revenue 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
65.41% · OPTIONAL · VALID
Capex intensity 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.76% · OPTIONAL · VALID
Operating cash generation 56th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.00% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-8.84% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
20.49% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
37.18% · CORE · VALID
Operating margin 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
11.23% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.02% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 50th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.78% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 26 states Self-history eligible
Dec 31, 2018 0/9 normalized Level 3 Mar 31, 2019 0/8 normalized Level 3 Jun 30, 2019 5/8 normalized Level 3 Sep 30, 2019 7/8 normalized Level 3 Dec 31, 2019 7/9 normalized Level 3 Mar 31, 2020 7/8 normalized Level 3 Jun 30, 2020 8/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Sep 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 267.10%
Current 65.41%
Delta -201.69% Capex Intensity Increased
Previous 1.52%
Current 1.76%
Delta 0.24% Cash Generation Decreased
Previous 19.14%
Current 14.00%
Delta -5.14% Growth Increased
Previous -13.43%
Current -8.84%
Delta 4.59% Inventory Pressure Decreased
Previous 90.38%
Current 20.49%
Delta -69.89% Margin Increased
Previous 37.12%
Current 37.18%
Delta 0.06% Profitability Decreased
Previous 12.22%
Current 11.23%
Delta -0.99% Sbc Intensity Increased
Previous -0.03%
Current 0.78%
Delta 0.82% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.